These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 7849060)
21. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Seo B; Oemar BS; Siebenmann R; von Segesser L; Lüscher TF Circulation; 1994 Mar; 89(3):1203-8. PubMed ID: 8124808 [TBL] [Abstract][Full Text] [Related]
22. The endothelin ETA receptor exists in the caudal solitary tract nucleus of the rat brain. Shibata S; Niwa M; Himeno A; Gana NG; Shigematsu K; Matsumoto M; Yamashita K; Sumikawa K; Taniyama K Cell Mol Neurobiol; 1997 Feb; 17(1):151-6. PubMed ID: 9118207 [TBL] [Abstract][Full Text] [Related]
23. Identification and function of putative ETB receptor subtypes in the dog kidney. Brooks DP; DePalma PD; Pullen M; Gellai M; Nambi P J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S322-5. PubMed ID: 8587403 [TBL] [Abstract][Full Text] [Related]
24. Endothelin-induced nociception in mice: mediation by ETA and ETB receptors. Raffa RB; Schupsky JJ; Jacoby HI J Pharmacol Exp Ther; 1996 Feb; 276(2):647-51. PubMed ID: 8632332 [TBL] [Abstract][Full Text] [Related]
25. The induction of a biphasic bronchospasm by the ETB agonist, IRL 1620, due to thromboxane A2 generation and endothelin-1 release in guinea-pigs. Noguchi S; Kashihara Y; Bertrand C Br J Pharmacol; 1996 Jul; 118(6):1397-402. PubMed ID: 8832063 [TBL] [Abstract][Full Text] [Related]
26. Solution conformation of endothelin-1 by 1H NMR, CD, and molecular modeling. Saudek V; Hoflack J; Pelton JT Int J Pept Protein Res; 1991 Mar; 37(3):174-9. PubMed ID: 1869369 [TBL] [Abstract][Full Text] [Related]
27. Role and mechanism of endothelin-B receptors in mediating ET-1-induced vasoconstriction in pig skin. Pang CY; Zhang J; Xu H; Lipa JE; Forrest CR; Neligan PC Am J Physiol; 1998 Oct; 275(4):R1066-74. PubMed ID: 9756535 [TBL] [Abstract][Full Text] [Related]
28. Solution conformation of an ET(B) selective agonist, ET-1[Cys(Acm)1,15,Ala3,Leu7,Aib11], in CD3OH/H2O by 1H NMR and molecular modelling. Hewage CM; Jiang L; Parkinson JA; Ramage R; Sadler IH FEBS Lett; 1998 Mar; 425(2):234-8. PubMed ID: 9559655 [TBL] [Abstract][Full Text] [Related]
29. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus. Hay DW; Luttmann MA; Beck G; Ohlstein EH Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345 [TBL] [Abstract][Full Text] [Related]
30. Endothelin ETA and ETB receptors facilitating parasympathetic neurotransmission in the rabbit trachea. Yoneyama T; Hori M; Tanaka T; Matsuda Y; Karaki H J Pharmacol Exp Ther; 1995 Dec; 275(3):1084-9. PubMed ID: 8531067 [TBL] [Abstract][Full Text] [Related]
31. A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Takai M; Umemura I; Yamasaki K; Watakabe T; Fujitani Y; Oda K; Urade Y; Inui T; Yamamura T; Okada T Biochem Biophys Res Commun; 1992 Apr; 184(2):953-9. PubMed ID: 1315540 [TBL] [Abstract][Full Text] [Related]
32. Conformation of sarafotoxin-6b in aqueous solution determined by NMR spectroscopy and distance geometry. Mills RG; Atkins AR; Harvey T; Junius FK; Smith R; King GF FEBS Lett; 1991 May; 282(2):247-52. PubMed ID: 2037041 [TBL] [Abstract][Full Text] [Related]
33. Subtypes of endothelin ETA and ETB receptors mediating venous smooth muscle contraction. Sudjarwo SA; Hori M; Tanaka T; Matsuda Y; Okada T; Karaki H Biochem Biophys Res Commun; 1994 Apr; 200(1):627-33. PubMed ID: 8166738 [TBL] [Abstract][Full Text] [Related]
34. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors. Rose PM; Krystek SR; Patel PS; Liu EC; Lynch JS; Lach DA; Fisher SM; Webb ML FEBS Lett; 1995 Mar; 361(2-3):243-9. PubMed ID: 7698331 [TBL] [Abstract][Full Text] [Related]
35. Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors. Filep JG; Fournier A; Földes-Filep E Br J Pharmacol; 1995 May; 115(2):227-36. PubMed ID: 7670725 [TBL] [Abstract][Full Text] [Related]
36. The crystal structure of human endothelin. Janes RW; Peapus DH; Wallace BA Nat Struct Biol; 1994 May; 1(5):311-9. PubMed ID: 7664037 [TBL] [Abstract][Full Text] [Related]
37. Decrease in endothelin-1 renal receptors during the 1st month of life in the rat. Abadie L; Blazy I; Roubert P; Plas P; Charbit M; Chabrier PE; Dechaux M Pediatr Nephrol; 1996 Apr; 10(2):185-9. PubMed ID: 8703708 [TBL] [Abstract][Full Text] [Related]
38. The development of potent peptide agonists and antagonists for the endothelin receptors. Cody WL; Doherty AM Biopolymers; 1995; 37(2):89-104. PubMed ID: 7893949 [TBL] [Abstract][Full Text] [Related]
39. The solution structure of human endothelin-2 a 1H-NMR and CD study. Arvidsson K; Nemoto T; Mitsui Y; Ohashi S; Nakanishi H Eur J Biochem; 1998 Oct; 257(2):380-8. PubMed ID: 9826183 [TBL] [Abstract][Full Text] [Related]
40. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies. Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]